Brain metabolism in rett syndrome: Age, clinical, and genotype correlations

✍ Scribed by Alena Horská; Luciano Farage; Genila Bibat; Lídia M. Nagae; Walter E. Kaufmann; Peter B. Barker; Sakkubai Naidu

• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 306 KB
• Volume: 65
• Category: Article
• ISSN: 0364-5134
• DOI: 10.1002/ana.21562

✦ Synopsis

Abstract

Objective

Brain metabolism, as studied by magnetic resonance spectroscopy (MRS), has been previously shown to be abnormal in Rett syndrome (RTT). This study reports the relation of MRS findings to age, disease severity, and genotype.

Methods

Forty RTT girls (1–14 years old) and 12 age‐matched control subjects were examined. Single‐voxel proton MRS of left frontal white matter was performed.

Results

NAA/Cr ratios decreased and myoinositol/Cr ratios increased with age in RTT patients (both p < 0.03), whereas these ratios were stable in control. The mean glutamate and glutamine/Cr ratio was 36% greater in RTT patients than in control (p = 0.043). The mean NAA/Cr ratio was 12.6% lower in RTT patients with seizures compared with those without seizures (p = 0.017). NAA/Cr ratios decreased with increasing clinical severity score (p = 0.031). Compared with patients with T158X, R255X, and R294X mutations, and C‐terminal deletions, patients with the R168X mutation tended to have the greatest severity score (0.01 ≤ p ≤ 0.11) and the lowest NAA/Cr ratio (0.029 ≤ p < 0.14).

Interpretation

Decreasing NAA/Cr and increasing myoinositol/Cr with age are suggestive of progressive axonal damage and astrocytosis in RTT, respectively, whereas increased glutamate and glutamine/Cr ratio may be secondary to increasing glutamate/glutamine cycling at the synaptic level. The relations between NAA/Cr, presence or absence of seizures, and disease severity suggest that MRS provides a noninvasive measure of cerebral involvement in RTT. Ann Neurol 2009;65:90–97